MegraudF.Epidemiology of Helicobacter pylori infection. Gastroenterol Clin North Am.1993; 22: 7388.
8.
ParsonnetJ., FriedmanG.D., VandersteenD.P.Helicobacter pylori infection and the risk of gastric carcinoma. N Engl J Med.1991; 325: 11271131.
9.
ParsonnetJ., HansenS., RodriguezL.Helicobacter pylori infection and gastric lymphoma. N Engl J Med.1994; 330: 12671271.
10.
ParsonnetJ.Helicobacter pylori and gastric cancer. Gastroenterol Clin North Am.1993; 22: 89104.
11.
Gastrointestinal Physiology Working Group.Helicobacter pylori and gastritis in Peruvian patients: relationship to socioeconomic level, age, and sex. Am J Gastroenterol.1990; 85: 819–823.
12.
ParsonnetJ., BlaserM.J., PerezPerezG.I.Symptoms and risk factors of Helicobacter pylori infection in a cohort of epidemiologists. Gastroenterology.1992; 102: 4146.
13.
ParsonnetJ., VandersteenD., GoatesJ.Helicobacter pylori infection in intestinal and diffusetype gastric adenocarcinomas. J Natl Cancer Inst.1991; 83: 640643.
14.
HazellS.L., HennessyW.B., BorodyT.J.Campylobacter pyloridis gastritis II: distribution of bacteria and associated inflammation in the gastroduodenal environment. Am J Gastroenterol.1987; 82: 297301.
15.
TalleyN.J., ZinsmeisterA.R., WeaverA.Gastric adenocarcinoma and Helicobacter pylori infection. J Natl Cancer Inst.1991; 83: 17341739.
16.
NomuraA., StemmermannG.N., ChyouP.H.Helicobacter pylori infection and gastric carcinoma among Japanese Americans in Hawaii. N Engl J Med.1991; 325: 1132–1136.
17.
FormanD., NewellD.G., FullertonF.Association between infection with Helicobacter pylori and risk of gastric cancer: evidence from a prospective investigation. Br Med J.1991; 302: 13021305.
18.
DooleyC.P., CohenH., FitzgibbonsP.L.Prevalence of Helicobacter pylori infection and histologic gastritis in asymptomatic persons. N Engl J Med.1989; 321: 1562–1566.
19.
RamseyE.J., CareyK.V., PetersonW.L.Epidemic gastritis with hypochlorhydria. Gastroenterology.1979; 76: 14491457.
20.
McNultyC.A., GeartyJ.C., CrumpB.Campylobacter pyloridis and associated gastritis: investigator blind, placebo controlled trial of bismuth salicylate and erythromycin ethylsuccinate. Br Med J.1986; 293: 645–649.
21.
RauwsE.A., LangenbergW., HouthoffH.J.Campylobacter pyloridisassociated chronic active antral gastritis: a prospective study of its prevalence and the effects of antibacterial and antiulcer treatment. Gastroenterology.1988; 94: 3340.
22.
MorganD., KraftW., BenderM.Nitrofurans in the treatment of gastritis associated with Campylobacter pylori: the Gastrointestinal Physiology Working Group of Cayetano Heredia and The Johns Hopkins Universities. Gastroenterology.1988; 95: 11781184.
23.
GlupczynskiY., BuretteA., LabbeM.Campylobacter pyloriassociated gastritis: a doubleblind placebocontrolled trial with amoxycillin. Am J Gastroenterol.1988; 83: 365–372.
YardleyJ.H.Pathology of chronic gastritis and duodenitis. In: GoldmanH., AppelmanH.D., KaufmanN., eds. Gastrointestinal Pathology.Baltimore, Md: Williams & Wilkins; 1990: 69121.
34.
DixonM.F.Progress in the pathology of gastritis and duodenitis. In: WilliamsG.T., ed. Gastrointestinal Pathology.Berlin, Germany: SpringerVerlag; 1990: 127.
35.
GoldmanH.Gastritis. In: MingS.C., GoldmanH., eds. Pathology of the Gastrointestinal Tract.Philadelphia, Pa: WB Saunders; 1992: 481–516.
36.
LewinK.L., RiddellR.H., WeinsteinW.M.Gastrointestinal Pathology and Its Clinical Implications.New York, NY: IgakuShoin; 1992: 508–537. Recent Classifications of Most of the Common Chronic Gastritides